Gilead Sciences GILD Q1 2026 Earnings Analysis Revenue Beats Forecast Amid Mixed Product Performance Is Washington WASH a once in a decade opportunity Investors Pile In 20260503 CNTX Context Therapeutics Q4 loss widens misses estimates by 29 shares drop 33 on earnings disappointment RLJA RLJ management cites steady hospitality sector recovery as top strategic focus for upcoming fiscal periods Global Firms Leverage AI at Indian Centers to InHouse Advertising Operations